IONTAS and FairJourney Biologics discover COVID-19 neutralizing antibodies
Two leading clinical research organizations (CROs) say they have identified neutralizing antibodies with great potential for monoclonal antibody treatment.
Archives for October 1, 2020
Vaccibody and Genentech in cancer vaccine R&D and commercialization tie-up
Oslo headquartered, Vaccibody, a pioneer in the neoantigen cancer vaccine space, has entered into an exclusive worldwide license and collaboration agreement with Genentech.
CPhI Festival of Pharma
CPhl event to draw attention to M&A activity in gene and cell sector
The recent M&A trend in the cell and gene therapy space will be put under the spotlight at the CPhl Festival of Pharma.